How to Launch an LED Therapy Mask Brand: A Decision Roadmap, Not a Checklist of Hype
Launching a device brand is not a sequence of sourcing steps. It needs a defensible customer proposition, a product scope that can actually be validated, a cost model with its assumptions written down, a market plan and a credible way to support the product after sale. A supplier can execute a product; it cannot make your commercial decisions for you. The test of readiness is not whether you can place an order — it is whether you can answer for the product once it is in someone’s hands.
Table of Contents
- 1. A Launch Is Not a Sourcing Sequence
- 2. Validate the Customer Problem First
- 3. Build the Unit Economics With Explicit Assumptions
- 4. Choose the Product and Manufacturing Model
- 5. Plan the Obligations After Launch
- 6. The First Order: One Number and Its Limits
- 7. What a Supplier Can and Cannot Help With
- 8. References & External Links
1. A Launch Is Not a Sourcing Sequence
Most “how to launch” content is a sourcing checklist with a marketing introduction: find a supplier, pick a model, put your logo on it, open a store. It reads as a plan because it has an order. What it leaves out is the part that determines whether the business survives its second year — who the customer is, why they would choose this product, what it costs to acquire them, and what happens when one of them has a problem.
A supplier sits at one point in this picture. It can build a product to a specification, evidence its performance and manufacture it consistently. It cannot decide your positioning, price your risk, or answer a customer’s complaint on your behalf. Treating the supplier as the source of the business case is the most reliable way to launch a product nobody has costed.
The sequence below is a decision roadmap rather than an execution plan. Our companion article on the stage-gate manufacturing process covers what happens once those decisions have been made; this page covers whether they have.
2. Validate the Customer Problem First
Before a product brief, there has to be a customer problem specific enough to design against. Five things need answers, and none of them comes from a keyword tool.
- The segment. Not “skincare consumers” — a group with a shared context, budget and level of patience for a routine.
- The use context. Evenings at home, a clinic add-on, a travel kit. The same device is a different product in each.
- The alternatives. What they buy now, including doing nothing. Your product competes with the second option more often than with a competitor’s.
- The purchasing criteria. What the decision actually turns on: price, a clinic’s recommendation, a review, a return policy, the look of the object.
- The unresolved need. The specific complaint about existing options that your product answers. If you cannot state it in one sentence, the brief will not state it either.
Test these with evidence that exists outside your own optimism: interviews, channel conversations, pre-orders, a waitlist with a payment step. Search volume tells you what people type; it does not tell you what they buy, and the gap between the two is where most launches fail.
Then decide, deliberately, what the product will and will not claim — and what evidence that claim would need. Claims about the benefits and safety of a health-related product must be truthful, not misleading, and substantiated before they are published[1]. Making that decision at the positioning stage is far cheaper than discovering at the copywriting stage that the claim you built the brand around has nothing behind it.
3. Build the Unit Economics With Explicit Assumptions
This is where businesses are lost quietly, because the model looks complete while three of its largest lines are placeholders. Nine cost lines belong in it, and the third column is the assumption that usually goes unwritten.
| Cost Line | One-Time or Per Unit | The Assumption People Forget to Write Down |
|---|---|---|
| Product cost | Per unit | Quoted at a volume you have not committed to, for a configuration you have not specified. |
| Tooling and engineering | One-time | Amortised across a first order that may never be repeated, which flatters the unit economics of that order. |
| Testing and certification | One-time, sometimes per variant | Scope assumed rather than quoted, and assumed to cover a second market it does not. |
| Packaging | One-time artwork, per-unit material | That each packaging variant may carry its own minimum order, multiplying the commitment. |
| Freight and duties | Per unit, volume-dependent | Calculated on the wrong Incoterm, or on a carton size that changed after tooling. |
| Channel margin | Per unit | A model built at direct-to-consumer prices, then sold through a distributor who needs their own margin. |
| Returns and warranty | Per unit, but uneven | Set to zero because the number is unknown — which is the one value it cannot be. |
| Customer acquisition | Per unit, variable | Often the largest line in the model and the least evidenced — estimated from an industry figure rather than your own channel test. |
| Support and spares | Per unit and per period | Omitted entirely, because it does not appear on any supplier’s quotation. |
Two habits make the model useful rather than decorative. Build scenarios — a base, a slow start and a launch that works — instead of a single optimistic forecast. And label every assumption that has not been confirmed by a supplier quotation or your own sales data, so that the difference between “known” and “hoped” survives the next revision of the spreadsheet.
We deliberately publish no margin, payback or timeline figures on this page. A number lifted from an article is worse than a blank cell, because a blank cell invites you to fill it in with your own data.
4. Choose the Product and Manufacturing Model
Decide whether an existing platform meets the intended requirements or whether customisation is genuinely necessary — and be suspicious of a “necessary” that has not been costed. The comparison is not only about price.
- Design ownership. Who holds the drawings and the tooling, and whether you could move production later. A lower unit price with no route out is a different offer from a slightly higher one with one.
- Lead-time dependencies. What has to happen before your order can start — tooling, artwork approval, your own sign-off. These are the dates that actually move.
- Minimum quantities. Per model, per configuration, per packaging variant. The number that decides whether a colour range is affordable or merely attractive.
- Future revisions. What a second version would cost, and whether the platform allows one at all without a new tool.
And one caution about this category specifically: do not choose a model because an article says ODM is always faster or cheaper. Both claims are conditional, and the conditions are the four items above. A roadmap that skips them is not a shortcut; it is a decision made by default.
5. Plan the Obligations After Launch
Launch readiness is often assessed as the ability to place a first order. The more useful test is the ability to respond when a real customer has a problem — which is a set of processes you need before you need them.
- Target-market requirements, confirmed not assumed. Including whether the documentation you have covers the market you are actually selling into, in the language and format required[2].
- A claims review before publication, not after. Every page, listing, FAQ and influencer brief. The claim that was never approved is the one that gets quoted.
- A support workflow with a route for medical questions. Who answers, within what time, and when the answer is “speak to a clinician” rather than a product explanation.
- Complaint escalation and adverse-event handling. A named path and a record. Improvising this on the first bad week is how a complaint becomes a pattern nobody tracked.
- Spare parts and change control. Straps, inserts and cables wear out; components get substituted. Both need an answer that predates the question.
6. The First Order: One Number and Its Limits
Rainbowdo reports a starting MOQ of 500 units. Use it as an initial planning assumption for inventory exposure and the cash a first order requires — not as a substitute for a quotation, and not as a statement about your configured product.
Three questions turn the assumption into a plan. Does the minimum apply per model or per configuration? What do packaging and logo customisation add, and do they carry their own minimum? And how do sample approval and production release affect the schedule you are building the cash flow around? The stated monthly capacity of 100,000 units is a separate figure again — the number that matters is what is available for your order in your target launch window.
None of this is a discouragement. It is the difference between a launch that is planned and one that is merely scheduled — and the difference usually becomes visible in month four, not on day one.
Working through the business case for a new LED device? Visit our
Custom Light Therapy Manufacturing Page.
7. What a Supplier Can and Cannot Help With
Rainbow Technology runs ODM and OEM programmes from our Shenzhen facility. It is worth being explicit about the boundary, because a supplier that blurs it is not helping you:
- What we can do: feasibility feedback on a specification, model-specific optical and thermal evidence, tooling and documentation scope, a configuration-specific quotation, and a manufacturing process you can audit.
- What we cannot do for you: choose your customer, set your price, substantiate a claim you have not evidenced, or answer a customer’s medical question. Those stay with the brand, and any supplier who offers to take them on is selling you a risk you will still own.
- Sample and small-batch production from 500 units, with a stated capacity of 100,000 units per month; both figures depend on model, configuration, packaging and schedule, and are confirmed in a formal quotation.
- Compliance documentation matched to the exact model for your target market. Where a model holds a 510(k) record we provide the K-number so you can check its scope in the FDA’s public database; clearance is not the same as FDA approval, and the scope differs from model to model.
8. References & External Links
[1] U.S. Federal Trade Commission.
Health Products Compliance Guidance (2022). Objective claims about the benefits and safety of health-related products must be truthful, not misleading, and substantiated before publication — the reason the claim decision belongs at the positioning stage.
[2] International Organization for Standardization.
ISO 20417:2026 Medical devices — Information to be supplied by the manufacturer. Second edition, published March 2026, replacing ISO 20417:2021; it sets the requirements for labelling, packaging and accompanying documentation — the obligations that begin the day the product ships, not the day a problem appears.
